Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Oct 26;62(44):e202216097.
doi: 10.1002/anie.202216097. Epub 2023 Jul 31.

Protein-based Nanoparticles: From Drug Delivery to Imaging, Nanocatalysis and Protein Therapy

Affiliations
Review

Protein-based Nanoparticles: From Drug Delivery to Imaging, Nanocatalysis and Protein Therapy

Jonas Kaltbeitzel et al. Angew Chem Int Ed Engl. .

Abstract

Proteins and enzymes are versatile biomaterials for a wide range of medical applications due to their high specificity for receptors and substrates, high degradability, low toxicity, and overall good biocompatibility. Protein nanoparticles are formed by the arrangement of several native or modified proteins into nanometer-sized assemblies. In this review, we will focus on artificial nanoparticle systems, where proteins are the main structural element and not just an encapsulated payload. While under natural conditions, only certain proteins form defined aggregates and nanoparticles, chemical modifications or a change in the physical environment can further extend the pool of available building blocks. This allows the assembly of many globular proteins and even enzymes. These advances in preparation methods led to the emergence of new generations of nanosystems that extend beyond transport vehicles to diverse applications, from multifunctional drug delivery to imaging, nanocatalysis and protein therapy.

Keywords: Drug Delivery; Enzymes; Nanoparticles; Polymers; Proteins.

PubMed Disclaimer

References

    1. D. J. Dietzen in Principles and Applications of Molecular Diagnostics (Eds.: N. Rifai, A. R. Horvath, C. T. Wittwer), Elsevier, Amsterdam, 2018, p. 345.
    1. None
    1. L. P. Herrera Estrada, J. A. Champion, Biomater. Sci. 2015, 3, 787;
    1. M. Tarhini, H. Greige-Gerges, A. Elaissari, Int. J. Pharm. 2017, 522, 172;
    1. S. Hong, D. W. Choi, H. N. Kim, C. G. Park, W. Lee, H. H. Park, Pharmaceutica 2020, 12, 604;

LinkOut - more resources